Skip to main content
. 2016 Feb 24;7(13):16384–16395. doi: 10.18632/oncotarget.7650

Table 2. Analysis of the progression-free survival based on the WHO histology and grade of gliomas.

Histology total Median PFS (days) 1-year PFS survival rate 2-year PFS survival rate 3-year PFS survival rate 4-year PFS survival rate 5-year PFS survival rate p value
LGG 100 830 84 55 27 13 7 < 0.0001
pA 50 693 82 50 28 14 8
pO 9 721 67 44 22 22 11
pOA 41 860 90 63 27 10 5
AG 47 495 68 32 15 6
pAA 10 611 70 50 20 10
pAO 5 792 100 60 40
pAOA 32 398 63 22 9 6
pGBM 64 394 52 16 6 2 2

Abbreviations: WHO, World Health Organization; PFS, progression-free survival; LGG, low grade glioma; pA, primary astrocytoma; pO, primary oligodendroglioma; pOA, primary oligoastrocytoma; AG, anaplastic glioma; pAA, primary anaplastic astrocytoma; pAO, primary anaplastic oligodendroglioma; pAOA, primary anaplastic oligoastrocytoma; pGBM, primary glioblastoma.